Approval · Notice of Compliance 9887 · 2008
THELIN: Notice of Compliance 9887
Issued November 10, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9887
- Date
- November 10, 2008
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Endothelin receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THELIN | 02295636 | Cancelled Post Market |
Medicinal ingredients
- SITAXSENTAN SODIUM 100 MG per TAB